Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin added to first-line chemotherapy in small cell lung cancer
ISRCTN56306957Phase 3Completed
- Sponsor
- University College London
- Start
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in small cell lung cancer (SCLC) comparing Pravastatin plus standard chemotherapy with Placebo plus standard chemotherapy (2 arms). Primary endpoint: Overall survival. Started Jun 2006; status: completed.
02
Drugs
pravastatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ISRCTN56306957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN56306957.